Bone is a dynamic organ that provides support and protection to vital organs. Bone also plays a role in the regulation of calcium homeostasis. The effects of two cell types, osteoblasts and osteoclasts, are critical for maintaining proper bone mass and shape. Osteoclasts are a member of the monocyte/macrophage family, while osteoblasts are of mesenchymal origin and responsible for mineralizing bone matrix \[[@CR1]\].

Cbl and Cbl-b are highly homologous members of a family of adaptor proteins that promote assembly of signaling complexes downstream of several receptors \[[@CR2]\]. Both function as E3 ubiquitin ligases that regulate ubiquitylation of proteins. Cbl proteins are known to participate in growth factor, cytokine, and integrin-mediated signaling pathways in various cell types. Tyrosine phosphorylation of Cbl upon receptor activation is one of the most common signaling phenomena shown to promote both its E3 ubiquitin ligase activity and adaptor function \[[@CR2]\].

Despite the marked effect of mutating Cbl \[[@CR3], [@CR4]\] or reducing its expression in vitro to affect osteoclast activity \[[@CR5]\], Cbl^−/−^ mice have a mild bone phenotype manifested primarily during endochondral bone formation \[[@CR6]\]. In contrast, absence of Cbl-b protein in mice results in osteopenia due to osteoclast hyperactivity \[[@CR7]\]. In spite of significant homology between Cbl and Cbl-b proteins, single knockouts of Cbl and Cbl-b have distinct bone phenotypes, suggesting specific roles for each protein in bone homeostasis. However, Cbl/Cbl-b double knockout mice die in utero around E10.5 \[[@CR8]\], suggesting that Cbl and Cbl-b also have overlapping functions. The major structural difference that could contribute to the unique function(s) of Cbl proteins includes a tyrosine present only in Cbl (CblY737), which when phosphorylated binds to the SH2 domain of the p85 subunit of phosphatidylinositol 3 kinase (PI3K) \[[@CR9]--[@CR11]\]. Other investigators have shown that Tyr^737^ is among several Tyr residues that are phosphorylated by Src family kinases \[[@CR12]\] and that when phosphorylated binds to the SH2 domain of the regulatory p85 subunit of PI3K \[[@CR10], [@CR11]\]. The absence of this residue in Cbl-b highlights a potential divergence in the role and mode of action of these two highly similar regulatory proteins, although this has not been examined with respect to osteoclast or osteoblast biology.

PI3Ks are a class of enzymes that phosphorylate phosphatidylinositol and its derivatives and regulate cell growth, the cytoskeleton, and cell survival \[[@CR13]\]. PI3K activation in various cell types, including osteoblasts, is often associated with increased tyrosine phosphorylation induced by growth and differentiation factors. The importance of PI3K in osteoblast function has been established \[[@CR14], [@CR15]\]. In several cell types, Cbl is known to be a major protein that interacts with PI3K and regulates its activity \[[@CR11], [@CR16]\]. Downregulation of Cbl induced by twist haploinsufficiency in Saethre-Chotzen syndrome results in increased PI3K/AKT signaling and osteoblast proliferation \[[@CR17]\]. In humans, osteoblasts expressing mutated FGFR2 levels of PI3K are decreased. The decreased PI3K signaling in response to FGFR2 activation is due to increased Cbl--PI3K molecular interaction mediated by the Cbl Y731 residue, which results in increased PI3K ubiquitylation and proteasome degradation \[[@CR18]\]. We recently reported that, on the one hand, the Cbl--PI3K complex negatively regulates osteoclast differentiation and survival while, on the other hand, it positively influences osteoclast function \[[@CR19]\].

In this report, we continued to study the role of Cbl--PI3K interaction in the skeletal system. Our results indicated that abrogation of the Cbl--PI3K interaction resulted in increased bone mass and increased trabecular and cortical bone volumes. The altered geometry of bone due to increased volume also resulted in increased mechanical properties. While osteoblast numbers were increased in mice, ex vivo differentiation and survival of the YF osteoblast was not significantly affected. Analysis of the conditioned medium derived from culturing YF bone marrow stromal cells, as well as the expression analysis of cells, showed increased expression of stromal cell derived factor-1 (SDF-1) and its receptor, CXCR4. Antibody-mediated ablation of SDF-1 activity attenuated cell proliferation. Taken together, these data and our previously published work suggest that abrogation of Cbl--PI3K interaction perturbs bone homeostasis, affecting both osteoclast function and osteoblast proliferation.

Materials and Methods {#Sec1}
=====================

Mice Colony {#Sec2}
-----------

The generation of CblY737F mice has been previously described \[[@CR20]\]. Mice were maintained in a mixed C57BL/6 × 129SvJ background, and experiments were performed in compliance with the Institutional Animal Care and Use Committee at Temple University.

Histological Analysis {#Sec3}
---------------------

To label the skeleton, calcein (i.p., 10 mg/kg body weight) was injected 9 and 2 days before death. After death, tibiae and femora of 12-week-old male mice were excised and cleaned of soft tissue. Bones were processed as previously described \[[@CR21]\]. Longitudinal sections (5 μM) were used to measure the fluorochrome label and then deplasticized and stained with Masson trichrome, as described previously \[[@CR21]\]. Histomorphometry was performed on three tissue sections per limb using a Nikon 800 fluorescence microscope linked to a Bioquant Osteo II system (R&M Biometrics, Nashville, TN). Dynamic parameters of bone formation were collected using unstained sections from the trabecular surface in a defined region of interest (100 μM below the growth plate and 50 μM in from the cortical bone) using a ×20 objective. Bone formation rate (BFR) was assessed by measuring single-labeled surface for single perimeter (sL.Pm), double-labeled surface (dL.Pm), and the interlabel distance in the dL.Pms. The same sections were then evaluated under polarized white light after Masson's trichrome staining to determine static parameters of bone formation: bone surface (BS), osteoid volume (OV), and osteoblast number (Ob.N). The following were then calculated: mineralizing surface (MS/BS, %), mineral apposition rate (MAR, mM/day), BFR (BFR/BS, MAR × \[MS/BS\]), OV (OV/BS), and (Ob.N/BS), as described previously \[[@CR22]\].

Immunohistochemistry {#Sec4}
--------------------

Alternate sections of the above bones were deplasticized, rehydrated, and then stained for SDF-1 and CXCR4 using previously described methods for detecting tissue cytokines \[[@CR23]\]. Specific antibodies for SDF-1 (rabbit SDF-1α, 1:250 dilution in PBS; Abcam, Cambridge, MA) and CXCR4 (rabbit CXCR4, 1:250 dilution in PBS; Abcam) were used. Primary antibodies were detected using anti-rabbit secondary antibodies tagged with Cy2 (green), Cy3 (red), or HRB (brown after enzymatic reaction with DAB). Sections were counterstained with DAPI or hematoxylin.

Micro-CT Analysis {#Sec5}
-----------------

High-resolution images of long bones from age-matched male mice were acquired using a Skyscan 1172, 12 MPix model (Microphotonics, Allentown, PA). Proximal tibiae and distal femora were scanned with the source voltage 59 kV, a source current of 167, and an isotropic voxel size of 6 μm. Imaging started at the distal end of the femur or the proximal end of the tibiae and included approximately 7 mm (1,335 slices) of the total bone length. After scanning, 3D image data were reconstructed using Sykscan (Aartselaar, Belgium) NRecon software; structural indices were calculated using the Skyscan CT Analyzer (CTAn) software. Using the CTAn software, trabecular bone was separated from cortical bone with a region of interest tool. Trabecular morphometric traits were computed from binarized images using direct 3D techniques that do not rely on prior assumptions from the underlying structures. The volume of interest for trabecular microarchitectural variables was bounded to the endocortical margin, starting 1.9 mm from the proximal tibial condyles, 0.2 mm distal to the growth plate, in the direction of the metaphysis, and then extending from this position for 100 slices (0.6 mm). Upper and lower thresholds of 255 and 80 were used to delineate each pixel as "bone" or "nonbone," and trabecular bone volume per total volume (BV/TV), BS (BS/TV), mean trabecular thickness (Tb.Th), mean trabecular number (Tb.N), and mean trabecular separation (Tb.Sp) indices were computed. For the analysis of cortical parameters, the mid-shaft of the femur was determined as 40% of the entire length of the bone. The cortical region of interest began at the mid-shaft and extended 100 slices (0.6 mm) toward the femoral head. Using upper and lower thresholds of 255 and 80, total area (T.Ar), periosteal perimeter (Ps.Pm), endosteal area (En.Ar), endosteal perimeter (En.Pm), cortical bone area (Ct.Ar), cortical thickness (Ct.Th), and relative cortical area (RCA) were computed.

Mechanical Testing {#Sec6}
------------------

Breaking strength of the right femur was measured under three-point bending using a material testing machine (ElectroForce Systems Group, Bose, Eden Prairie, MN) fitted with a 1,000 N load cell as previously described \[[@CR24], [@CR25]\]; to minimize the effect of shear loading, the distance between the lower support points was maximized. Femora were placed on the loading fixture anterior side down and loaded in the anterior--posterior plane at a span length of 19.26 mm. Prior to testing, bones were thawed in saline at room temperature to ensure hydration. Femora were loaded to failure at a rate of 0.05 mm/s, during which displacement and force were collected (100 Hz). Force and displacement values were normalized using terms derived from engineering analysis of three-point bending. Bending moments were calculated from the force (*F*) data (*M* = *FL*/4) (Nmm). Displacement data were divided by *L*^2^/12 (mm/mm^2^), where *L* is the distance between the lower supports (19.26 mm). Whole-bone mechanical properties were then determined from the moment versus normalized displacement curves, including peak moment (Nmm, ultimate load the specimen sustained), yield moment (Nmm), stiffness (Nmm^2^, the slope of the initial linear portion of the moment--displacement curve), yield displacement (mm/mm^2^, displacement at the yield point), postyield displacement (mm/mm^2^), work to failure (Nmm-mm/mm^2^, the area under the moment--displacement curve before failure), and work to failure postyield (Nmm-mm/mm^2^). The yield point was calculated as the point where a 10% change in the slope of the moment versus normalized displacement curve occurred.

Cell Culture {#Sec7}
------------

Calvarial osteoblasts were obtained from pups 3--5 days old as previously described \[[@CR26]\]. Typically, cells from three calvaria were plated in T-75 flasks in medium supplemented with 10% FBS. Culture medium was changed every third day until cells reached confluence. Cells were harvested and frozen until further use. For osteoblast differentiation in a typical experiment, 5 × 10^5^ cells were plated in a 6 cm dish and cultured in the presence of 10% fetal bovine serum (FBS; Thermo Fisher Scientific, Pittsburg, PA). "Complete medium" is 10% FBS containing α-MEM. Differentiation of cells in the above medium was initiated by adding 50 mM ascorbic acid and 5 mM glycerophosphate (Sigma, St. Louis, MO). Osteogenic medium was changed every third day. On day 14 osteoblasts were stained for alkaline phosphatase (ALP) and assessed for ALP activity according to the manufacturer's protocol (Sigma). ALP activity was normalized to the total protein content of cell lysates. Protein concentrations were quantified by a BCA protein assay (Pierce, Rockford, IL). On day 21 osteoblasts were stained with alizarin red, and staining was quantified using the Bioquant Osteo II (Nashville, TN) program.

Bone marrow stromal cells were isolated from the hind limbs of mice aged 6--8 weeks. The proximal and distal ends of the hind limbs were cut to allow the marrow to be flushed with complete medium. Bone marrow cells were filtered through a 70 μ nylon mesh filter (BD, Falcon, Oxnard, CA). Following lysis of RBCs using ammonium chloride lysis buffer, cells were collected by centrifugation and resuspended in complete medium. Cells (25 to 30 × 10^7^) were plated into T-75 tissue culture flasks. Nonadherent cells were removed after 16--18 h. Adherent cells were cultured until they became 70--80% confluent. Cell culture was treated with 0.025% trypsin containing 0.02% EDTA for 2 minutes at room temperature. To generate conditioned medium, cells (1 × 10^7^) were seeded in a 6 cm dish and cultured in the presence of complete medium for 5 days at 37°C, 5% CO~2~. On the fifth day, medium was removed, centrifuged at 1,500 rpm for 5 min, filtered through 22 μ filters, and either used immediately or stored at −80°C. Cells were harvested for analysis in protein markers by real-time PCR as described below. For colony-forming unit (CFU) assay, bone marrow-derived cells were used as previously described \[[@CR27]\]. Briefly, bone marrow cells (1.5 × 10^5^ cells cm^−2^) were plated in complete medium and cultured for 5 days. Then, one-third of the medium was replaced with complete medium every third day. After 20 days, cells were fixed with 3.7% formaldehyde and stained with KaryoMax Giemsa stain or ALP (Sigma) according to the manufacturer's protocol. Cells were visualized using an E300 microscope at 10× magnification to count the number of colonies. Cells in clusters of 20 or more were counted as one colony.

For the proliferation assay, 10,000 cells were plated/well in a 96-well plate in quadruplets. After 18--20 h in culture in complete medium, cells were washed with serum-free medium and then incubated with appropriate medium or growth factors. After 72 h, cells were washed three times with cold PBS. A proliferation assay was performed using the Cyquant Cell Proliferation Kit (Molecular Probes, Eugene, OR) per the manufacturer's protocol. Fluorescence was measured using a Wallac 1420 fluorometer (PerkinElmer and Analytical Sciences, Turku, Finland), and cell proliferation was expressed as a percent of proliferation in 10% FBS-containing medium. In some experiments, prior to addition to cells, conditioned medium was treated with appropriate antibodies (10 μg/ml) and this solution was mixed end on end for 1 h at 4°C. In other experiments, cells were incubated with antibodies (10 μg/ml) for 1 h at 37°C prior to the addition of condition medium. Cell lysates were prepared in mRIPA lysis buffer (50 mM Tris-HCl \[pH 8.0\], 150 mM NaCl, 0.5% NP40, 0.25% sodium deoxycholate, protease inhibitors, 1 mM PMSF, 1 mM Na~2~VO~3~, 50 mM NaF) and lysates were processed for electrophoresis and Western blotting analysis as previously described \[[@CR19]\].

Real-Time PCR Analysis {#Sec8}
----------------------

The expression levels of osteoblast markers were analyzed by quantitative real-time PCR. RNA isolation was performed using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. RNA (1 μg) was transcribed using Super Script II reverse transcriptase (Invitrogen), following the manufacturer's protocol. Oligo(dT) and dNTPs were purchased from Promega (Madison, WI). Quantitative real-time PCR was performed using 1 μl of cDNA and SYBR Green PCR master mix (Applied Biosystems, Foster City, CA) on an Applied Biosystems 7500 real-time PCR system. Gene expression levels were normalized to GAPDH and calculated using the ΔΔCt method. Primers were designed using mRNA sequences obtained from Mouse Genomics Informatics and the Primer3 program (<http://sourceforge.net/projects/primer3/>). The following primers were used: SDF-1, AGTAGTGGCTCCCCAGGTTT (sense) and GAGACAGTCTTGCGGACACA (antisense); CXCR4, TCAGTGGCTGACCTCCTCTT (sense) and TTTCAGCCAGCAGTTTCCTT (antisense); Col1A, TGAACGTGACCAAAAACCAA (sense) and GCAGAAAAGGCAGCATTAGG (antisense); RUNX2, CCCAGCCACCTTTACCTACA (sense) and TATGGAGTGCTGCTGGTCTG (antisense); BSP, AAAGTGAAGGAAAGCGACGA (sense) and GTTCCTTCTGCACCTGCTTC (antisense); GAPDH, AACTTTGGCATTGTGGAAGG (sense) and ACACATTGGGGGTAGGAACA (antisense).

Analysis of Cytokines {#Sec9}
---------------------

Conditioned medium from bone marrow stromal cells was generated as described above and then sent for analysis to Searchlight Aushon Bio Systems (Billerica, MA) to determine the presence of cytokines and chemokines. Briefly, a multiplex ELISA was performed using the conditioned medium and the antibody to the protein of interest. Samples were diluted 1:2, 1:50, and 1:1,000 and tested in duplicate. A standard curve was established from the dilutions of the samples. Then, a mean value for the cytokine of interest was determined from the standard curve and reported as picograms per milligram total protein. Protein estimation of the conditioned medium was performed using the BCA kit. The results of the cytokine assays were normalized to the protein concentration for each sample.

Statistics {#Sec10}
----------

All experiments were performed at least three times, and differences between wild type (WT) and YF were determined using Student's *t* test. All statistics were generated from Prism 4.0 program (GraphPad, San Diego, CA). Differences were considered significant at *P* \< 0.05, and all data are represented as means ± SEM. For mechanical testing, body weights of mice in each group were normalized with a linear regression--based correction as previously described \[[@CR28]\].

Results {#Sec11}
=======

Abrogation of Cbl--PI3K Interaction Results in Increased Cortical and Trabecular Bone {#Sec12}
-------------------------------------------------------------------------------------

To understand the role of the Cbl--PI3K interaction in skeletal remodeling, we employed knock-in mice (CblY737F/Y737F, henceforth YF mice) in which the PI3K binding site on Cbl was ablated. Gross analysis revealed that YF mice were smaller in size and had decreased body weight compared to control pups (Fig. [1](#Fig1){ref-type="fig"}a, b). The delayed growth was first apparent 3 days after birth (data not shown) and continued for 9--18 days. The delay in growth occurred simultaneously with a lag in the growth of long bones (Fig. [1](#Fig1){ref-type="fig"}c). Histological analysis of bones from 9-day-old YF pups showed a significant delay in the formation of secondary spongiosa (data not shown). Histological analysis of tibial sections from 12-week-old mice stained with von Kossa showed that cancellous bone was increased in YF relative to age-matched control mice (Fig. [1](#Fig1){ref-type="fig"}d). However, weight and total tibial length were comparable between 12-week-old WT and YF mice (Fig. [1](#Fig1){ref-type="fig"}e, f). YF mice had a slight but significant decrease in body length from tail to snout (Fig. [1](#Fig1){ref-type="fig"}g). This matches prior reports of short stature on postnatal day 9, decreased bone length, and delayed formation of secondary ossification centers in Cbl^−/−^ mice \[[@CR6]\], although adult Cbl^−/−^ mice do not exhibit any overt skeletal phenotype. We also examined bone architecture of 12-week-old mice by micro-CT analysis (Fig. [2](#Fig2){ref-type="fig"}a, b) and, in agreement with our histological analysis, found increased trabecular bone volume in YF mice (Table [1](#Tab1){ref-type="table"}). Similarly, Ct.Ar was significantly increased due to the increased Ps.Pm and Ct.Th in YF mice (Table [1](#Tab1){ref-type="table"}). Taken together, these results suggest that lack of interaction between Cbl and PI3K results in increased bone volume.Fig. 1Disruption of Cbl--PI3K interaction results in a growth delay in young mice. **a** At 9 days old, YF mice are smaller than their counterpart WT mice. Delayed growth in 9-day-old YF mice resulted in decreased total body weight (**b**) and decreased tibial length (**c**). **d** Representative histological sections of proximal tibiae of 12-week-old WT and YF mice stained with von Kossa and counterstained with toluidine blue show increased mineralized bone in YF mice. Images were taken using a 10× objective. Twelve-week-old male WT and YF mice have similar weights (**e**) and tibial lengths (**f**). **g** Twelve-week-old YF mice have shorter body lengths. *n* = 8 mice per genotype. Mean ± SEM. \**P* \< 0.05 compared to WTFig. 2Disruption of Cbl--PI3K interaction in mice perturbs trabecular and cortical bone architecture. **a** The trabecular region of proximal tibiae was scanned starting at the proximal end and included approximately 7 mm (1,335 slices) of the total bone length. *Top* and *bottom panels* represent a 3D reconstruction of trabecular bone. **b** The cortical bone analysis began at 40% from the distal end of the femur and included 100 sections proximal from that point. *Top panel* represents a 3D reconstruction of the cortical bone at mid-shaft. *Bottom panel* represents a 2D section of the cortical bone, taken 0.3 mm (50 slices) from the mid-shaft toward the femur. Micro-CT was performed on six mice per genotype. Representative scanned images are shownTable 1Analysis of trabecular and cortical bone parameters from 12-week-old WT and YF miceWTYFTrabecular bone Bone volume/tissue volume (BV/TV, %)9.27 ± 1.6914.36 ± 1.51\* Bone surface/tissue volume (BS/TV, %)9.29 ± 1.1111.73 ± 0.36\* Trabecular thickness (Tb. Th., mm)0.047 ± 0.0010.056 ± 0.003\* Trabecular number (Tb. N., 1/mm)2.00 ± 0.322.80 ± 0.17\* Trabecular separation (Tb. Sp., mm)0.230 ± 0.0210.189 ± 0.004\*Cortical bone Total area (T.Ar, mm^2^)1.50 ± 0.091.77 ± 0.08\* Periosteal perimeter (Ps.Pm (mm)4.82 ± 0.145.18 ± 0.12\* Endosteal area (En.Ar, mm^2^)0.75 ± 0.040.88 ± 0.03\* Endosteal perimeter (En.Pm, mm)3.26 ± 0.063.50 ± 0.09\* Cortical bone area (Ct.Ar, mm^2^)0.82 ± 0.060.95 ± 0.05\* Cortical thickness-2D (Ct.Th, mm)0.183 ± 0.0060.200 ± 0.003\*\* Relative cortical area (RCA)0.55 ± 0.020.54 ± 0.01 Polar moment of inertia (J, mm^4^)0.313 ± 0.0410.424 ± 0.039\*Table represents the parameters of trabecular and cortical bone obtained through micro-CT analysis. *n* = 10 mice/genotype. Mean ± SEM\* *P* \< 0.05, \*\* *P* \< 0.01 compared to WT, respectively

Static and Dynamic Parameters of Bone Formation are Increased in YF Mice {#Sec13}
------------------------------------------------------------------------

We recently reported that although YF osteoclasts are unable to resorb bone in vivo, their numbers are significantly increased in YF mice \[[@CR19]\]. Given that bone volume can also be increased due to increased osteoblast numbers, we examined osteoblasts in YF and WT mice. Histological analysis of tibiae stained with Masson trichome (Fig. [3](#Fig3){ref-type="fig"}a) revealed a significant increase in osteoblast numbers and a 63% increase in osteoid (unmineralized bone) in YF sections (Fig. [3](#Fig3){ref-type="fig"}b, c). Histomorphometric analysis of calcein-labeled sections indicated that the normalized MS/BS, MAR, and BFR/BS were significantly increased in YF samples (Fig. [3](#Fig3){ref-type="fig"}d--g). Taken together, the above results indicate that in the absence of Cbl--PI3K interaction increased bone volume in mice is due not only to the decreased osteoclast-mediated bone resorption reported previously by our group \[[@CR19]\] but also to increased bone formation by osteoblasts.Fig. 3Bone formation is increased in YF mice. **a** Tibial sections from 12-week-old WT and YF were stained with Masson's trichrome (400× magnification). Quantification of osteoblasts/bone surface (N.Ob/BS) (**b**) and osteoid/BS (**c**). **d** Dynamic parameters of bone formation were assessed using tibiae harvested from 12-week-old WT and YF that were injected with calcein as described in [Materials and Methods](#Sec1){ref-type="sec"}. Representative photomicrographs of calcein double labeling (40×) in WT and YF in cortical bone (*upper panels*) and in trabeculae (*lower panels*) are shown. **e** Mineralized surface/bone surface (MS/BS, %). **f** Mineral apposition rate (MAR, μm^2^/day). **g** Bone formation rate/bone surface (BFR/BS, μm^2^/μm/day). *n* = 6 mice per genotype. Mean ± SEM. \**P* \< 0.05, compared to WT

Lack of Cbl--PI3K Interaction Confers Increased Bone {#Sec14}
----------------------------------------------------

While structural changes in bone are most likely to be detected in trabecular bone, we also observed structural changes in cortical bone in YF mice. A significant increase in total bone area (*P* \< 0.05 vs. WT) as well as increased Ps.Pm, En.Pm, and En.Ar (*P* \< 0.05 vs. WT, each) led to an increase in overall size of the cortical bone (Table [1](#Tab1){ref-type="table"}). In addition, polar moment of inertia was significantly greater in YF mice. The RCA did not change between groups, although there was an overall increase in cortical thickness (Table [1](#Tab1){ref-type="table"}). Imbalances between bone resorption and bone formation can affect bone geometry, affecting its ability to resist damage (fracture). Given that YF mice have increased cancellous bone (Fig. [1](#Fig1){ref-type="fig"}d; Table [1](#Tab1){ref-type="table"}) and increased cortical bone size (Table [1](#Tab1){ref-type="table"}), we examined the mechanical properties of the long bones using a three-point bending assay, as previously described \[[@CR24], [@CR25]\]. There was a significant increase in peak moment and yield displacement in YF mice compared to WT, but no differences were observed in the other parameters listed in Table [2](#Tab2){ref-type="table"}. These data suggest that the structural and geometric changes in YF bones could potentially be a compensatory mechanism to maintain bone strength since both size and the quality of the bone contribute to whole-bone strength.Table 2Mechanical properties of bone from 12-week-old WT and YF miceWTYFPeak moment (Nmm)32.30 ± 1.2338.24 ± 2.75\*Yield moment (Nmm)28.78 ± 1.4131.49 ± 2.70Stiffness (Nmm^2^)1222 ± 74.11209 ± 124.4Yield displacement (mm/mm^2^)0.02 ± 0.0010.05 ± 0.01\*Postyield displacement (mm/mm^2^)0.004 ± 0.0010.002 ± 0.002Work to failure (Nmm\*mm/mm^2^)0.61 ± 0.070.76 ± 0.16Work to failure postyield (Nmm\*mm/mm^2^)0.18 ± 0.040.22 ± 0.08Femora were placed on the prongs of a materials testing machine. A constant load of 0.05 mm/s was applied to femora until bone failure, during which displacement and force were collected at 100 Hz. Force and displacement values were normalized using terms as described in [Materials and Methods](#Sec1){ref-type="sec"}. Whole-bone mechanical properties were determined from the moment vs. normalized displacement curves. *n* = 10 mice/genotype. Mean ± SEM\* *P* \< 0.05 compared to WT

In the Absence of Cbl--PI3K Interaction Bone Marrow-Derived Osteoblasts Show Increased Col1A Expression {#Sec15}
-------------------------------------------------------------------------------------------------------

We previously reported that YF mice have increased osteoclast numbers and enhanced differentiation \[[@CR19]\]. Given that the numbers of osteoblasts are also significantly increased in YF mice (Fig. [3](#Fig3){ref-type="fig"}b), we next examined if similar increases in numbers were seen in ex vivo culture conditions. To assess the ability of osteoblasts to differentiate in vitro, calvarial osteoblasts or bone marrow stromal cells from WT and YF mice were treated with osteogenic media for 14 or 21 days. No appreciable differences were observed in the expression levels of Col-1A, BSP, and Runx2 between WT- and YF-derived calvarial osteoblasts and no significant differences were observed in ALP and von Kossa staining (Fig. [4](#Fig4){ref-type="fig"}a--c and data not shown). In contrast, in YF bone marrow stromal cell cultures, expression levels of Col1A were significantly increased during differentiation compared to WT samples (Fig. [4](#Fig4){ref-type="fig"}d), while expression levels of BSP and Runx2 were not appreciably altered (Fig. [4](#Fig4){ref-type="fig"}e, f). Histochemical analysis of in vitro cultures demonstrated comparable levels of ALP and alizarin red activity between WT and YF samples (Fig. [4](#Fig4){ref-type="fig"}g--j). Taken together, these data suggest that, unlike YF osteoclasts, which exhibit enhanced differentiation due to the upregulation of transcription factors NFATc1 and NFκB \[[@CR19]\], for the most part ex vivo osteoblast differentiation and the expression of transcription factor that regulates osteoblastogenesis are not significantly affected in the absence of Cbl--PI3K interaction.Fig. 4Differentiation of calvarial and bone marrow stromal cells in ex vivo culture. **a**--**f** WT and YF primary calvarial or bone marrow stromal cells were differentiated in osteogenic media for 0, 14, or 21 days, as indicated. Osteogenic medium was changed every third day. Expression levels of Col-1A (**a**, **d**), BSP (**b**, **e**), and Runx-2 (**c**, **f**) were analyzed by real-time PCR in calvarial osteoblasts (COB) and bone marrow stromal cells (BM). **g** Bone marrow stromal cells stained for ALP activity. **h** ALP activity. **i** Bone marrow stromal cells stained with alizarin red S to assess calcium deposition. **j** Alizarin red S stain was released from the cell matrix and quantified. All experiments were performed three times. A representative sample of three experiments is shown. Mean ± SEM. \**P* \< 0.05 compared to WT

Osteoblast Proliferation is Upregulated in the Absence of Cbl--PI3K Interaction {#Sec16}
-------------------------------------------------------------------------------

Trabecular and endocortical bone formation are directly correlated with the number of marrow-derived osteoprogenitors. Histological analysis of long bones indicated that in the absence of Cbl--PI3K interaction there is a twofold increase in osteoblast numbers (Fig. [3](#Fig3){ref-type="fig"}b) and increased MAR (Fig. [3](#Fig3){ref-type="fig"}f). Also, in contrast to calvarial cells, there was a significant increase in the expression of Col-1A when YF bone marrow-derived stromal cells were cultured in osteogenic medium (Fig. [4](#Fig4){ref-type="fig"}d). These data suggest that in the absence of Cbl--PI3K interaction, there might be increased potential for the bone marrow precursors to differentiate into osteoblasts and/or that osteoblasts have augmented proliferative capacity. To determine if the numbers of osteoblast progenitors were affected in YF mice, the number of CFUs was determined from bone marrow-derived cells. Although, the total numbers of marrow cells were comparable between the WT and YF mice (data not shown), there was a significant increase in CFUs for YF samples (Fig. [5](#Fig5){ref-type="fig"}a) and the potential of these cells to proliferate was increased compared to WT cells (Fig. [5](#Fig5){ref-type="fig"}b). We also observed a slight, but not statistically significant, increase in the proliferation rate of YF calvarial osteoblasts (data not shown).Fig. 5Proliferation of YF osteoblasts is increased. **a** Bone marrow stromal cells were cultured for 20 days in 10% FBS-containing medium. Cells were fixed and stained with Giemsa; clusters of 20 or more cells were counted as a colony. **b** Bone marrow stromal cells from WT and YF were seeded in a 96-well plate in complete medium for 72 h, and proliferation was assessed by the Cyquant method, as described in [Materials and Methods](#Sec1){ref-type="sec"}. **c** MC3T3-E1 cells were cultured in the presence of serum-free medium, 10% FBS, or osteoclast-conditioned medium derived from WT or YF osteoclasts. Cell proliferation was assessed as described above. **d** MC3T3-E1 were treated with serum-free medium, 10% FBS, or bone marrow conditioned medium derived from WT or YF bone marrow cultures. Cell proliferation was assessed as described above. **e**--**h** Calvarial and bone marrow stromal cells were cultured in complete medium for 5 days. Expression levels of SDF-1 (**e**, **g**) and CXCR4 (**f**, **h**) were measured by quantative real-time PCR. Data are presented as fold difference of expression between WT and YF culture. All experiments were performed three times, and a representative is shown. Mean ± SEM. \**P* \< 0.05 compared to WT

PI3K is known to regulate cell survival, and we previously reported that abrogation of Cbl--PI3K resulted in enhanced osteoclast survival \[[@CR19]\]; however, no differences were observed between the survival of WT and YF bone marrow-derived stromal cells (Supplementary Fig. 1). We also examined whether increased proliferation in YF osteoblasts was influenced by extracellular growth factors known to influence osteoblast proliferation. Treatment with several growth factors resulted in a similar level of proliferation in both WT and YF cells (Supplementary Fig. 2a). In response to addition of EGF, FGF, IGF, and PDGF to the cultures, phosphorylation of p85 and AKT was comparable in WT and YF samples (Supplementary Fig. 2b).

In addition to their resorptive activity, osteoclasts are known to secrete factors that promote anabolic activity \[[@CR29], [@CR30]\]. Since YF mice had increased numbers of osteoblasts and osteoclasts (Fig. [3](#Fig3){ref-type="fig"}b and \[[@CR19]\]), we next examined the possibility that osteoclast-dependent secretory factors may promote increased YF osteoblast proliferation. WT and YF osteoclasts were generated in ex vivo cultures as previously described \[[@CR19]\] and the culture medium on day 5 of differentiation was collected. To analyze if the factors secreted from osteoclasts promote proliferation, MC3T3-E1 cells were grown in the osteoclast-derived culture medium. No significant differences were observed in the proliferation rate when cells were cultured in WT osteoclast-conditioned medium versus YF osteoclast-conditioned medium (Fig. [5](#Fig5){ref-type="fig"}c). This result suggests that, under these experimental conditions, factors secreted by YF osteoclasts may not contribute to the observed enhanced YF osteoblast proliferation.

Increased Levels of SDF-1 in YF Bone Marrow {#Sec17}
-------------------------------------------

The bone marrow niche contains a variety of cell types in various stages of maturation/differentiation. Many of these cell types secrete factors that can affect osteoblast proliferation. Therefore, we next examined if other factor(s) secreted by resident bone marrow cells could influence osteoblast proliferation. For this experiment, bone marrow stromal cells from WT and YF mice were cultured in the presence of 10% FBS-containing medium for 5 days. The resulting supernatant was used as the bone marrow conditioned medium. Proliferation of MC3T3-E1 cells was examined in response to WT and YF conditioned media. Compared to WT, treatment with YF conditioned medium induced increased proliferation of MC3T3-E1 cells (Fig. [5](#Fig5){ref-type="fig"}d), suggesting that a factor(s) present in the YF bone marrow-derived medium might contribute to the increased cell proliferation.

Analysis of the conditioned media using multiplex ELISAs indicated that the levels of IL-1β, IL-18, MCP-1, RANTES, and TGF-1β were comparable in WT and YF samples (Table [3](#Tab3){ref-type="table"}). Only levels of SDF-1, a chemokine known to be present in the bone marrow milieu, were significantly increased in the YF bone marrow conditioned medium (Table [3](#Tab3){ref-type="table"}). We next determined mRNA expression levels of SDF-1 and its receptor, CXCR4, in calvarial osteoblasts and bone marrow stromal cells. For these experiments, cells were cultured in the presence of 10% FBS for 5 days before harvesting. RT-PCR analysis showed that SDF-1 and CXCR4 levels were comparable in WT and YF calvarial cells (Fig. [5](#Fig5){ref-type="fig"}e, f). In contrast, compared to expression levels in WT bone marrow stromal cells, YF bone marrow stromal cells showed \~2.5- and 3.5-fold increases in the expression levels of SDF-1 and CXCR4, respectively (Fig. [5](#Fig5){ref-type="fig"}g, h). This expression was then verified by immunohistochemistry. Staining of YF tibial sections with anti-SDF-1 antibodies showed enhanced staining in many bone stromal cells but no staining in mature osteoblasts adjacent to the trabeculae (Fig. [6](#Fig6){ref-type="fig"}b, c, i). Both stromal cells and osteocytes in sections from YF samples demonstrated increased CXCR4 staining compared to WT samples (Fig. [6](#Fig6){ref-type="fig"}f, j, h, l). For validation, bone marrow proliferation assays were performed using neutralizing antibodies against SDF-1 or CXCR4. Enhanced proliferation of MC3T3-E1 cells in response to YF conditioned medium was significantly decreased in the presence of neutralizing antibodies (Fig. [7](#Fig7){ref-type="fig"}). Taken together, these data suggest that in YF mice cell proliferation is increased, at least in part, due to increased SDF-1 present in the bone marrow milieu. However, our results do not eliminate the possibility that other factors may also contribute to the increased osteoblast proliferation.Table 3Expression of cytokines in WT and YF bone marrow-derived conditioned mediumWTYFIL-1β0.003 ± 0.00050.004 ± 0.0005IL-180.02 ± 0.0070.02 ± 0.005MCP-11.48 ± 0.801.11 ± 0.83RANTES0.01 ± 0.0090.008 ± 0.002TGF-β14.44 ± 0.704.71 ± 1.54SDF-10.04 ± 0.010.10 ± 0.03\*Table represents levels for each protein tested using a multiplex ELISA. The concentration of each factor was normalized to the total amount of protein present in the conditioned medium for each sample and expressed as picograms of cytokine per micrograms of protein. Mean ± SEM\* *P* \< 0.05 compared to WTFig. 6Bone marrow stromal cells from YF mice show enhanced SDF-1 and CXCR4 expression. Representative sections of proximal tibiae from 12-week-old WT and YF immunostained with either anti-SDF-1α (HRP-DAB or secondary antibody tag), anti-CXCR4, or DAPI. In all images, area indicated with *asterisk* is enlarged in inset. **a** WT tibial section showing only low-level SDF-1 staining in bone marrow stromal cells. *Inset* shows an absence of SDF-1 staining in osteocytes or quiescent bone lining cells on trabecular bone. **b** YF tibial section showing SDF-1 staining in many bone stromal cells. *Inset* shows SDF-1 staining in many stromal cells, including cells surrounding the trabecular bone, but no staining in osteoblasts (ob). Sections in **a** and **b** are lightly counterstained with hematoxylin and eosin (H&E). **c** YF tibial section with SDF and DAPI labeling showing SDF-1-stained cells in the bone marrow (bm) but not in cells lining the trabecular bone (tb). **d** YF tibial cortical bone showing increased numbers of osteocytes (os) expressing CXCR4. **e** WT tibial section showing SDF-1 staining in only a few of bone marrow cells but no staining in trabecular bone. *Inset* shows SDF-1 staining in only a few stromal cells. **f** Same section as shown in **e** showing an absence of CXCR4 staining. **g** Same section showing DAPI staining. **h** Merged **e**--**g** panels. *Inset* shows a low number of SDF + DAPI-stained stromal cells. **i** YF tibial section showing high levels of SDF-1 staining in many bone marrow stromal cells but none in trabecular bone. *Inset* shows SDF-1 in the cytoplasm of these cells. **j** Same section as in **i** showing increased CXCR4 staining in several stromal cells. Some, but not all, of the CXCR4-stained cells are double-labeled with SDF-1. *Inset* shows CXCR4 staining in the same cells as shown in inset in **i**. **k** Same section showing DAPI staining. **l** Merged **i**--**k** panels. *Inset* shows SDF + DAPI-stained stromal cells. All images were taken using a 40× objective. *Scale bar* in **l** = 20 μm. bv, blood vesselFig. 7Increased proliferation of cells in YF conditioned medium is mediated by SDF-1. MC3T3-E1 cells were cultured in the presence of serum-free medium, 10% FBS, or condition medium derived from WT or YF bone marrow cells. To assess the effect of SDF-1, 10 μg/ml of neutralizing anti-SDF-1 antibodies or isotype control antibodies was added to the conditioned medium. To determine the role of CXCR4, MC3TC-E1 cells were pretreated with 10 μg/ml neutralizing anti-CXCR4 antibodies. The cell proliferation assay was performed as described above. Cell proliferation is expressed as a percent of control (10% FBS-treated cells). Mean ± SEM. Symbols indicate *P* \< 0.05 for the following comparisons: *a* FBS versus YF, *b* WT versus YF, *c* YF versus IgG, *d* YF versus YF + α-SDF-1, *e* IgG versus YF + α-SDF-1, *f* YF versus YF + α-CXCR4, *g* IgG versus YF + α-CXCR4

Discussion {#Sec18}
==========

Cbl proteins are known to play a role in osteoclast migration and function as well as in osteoblast differentiation downstream of the FGF pathway by ubiquitylating and degrading the Src family kinases Lyn and Fyn \[[@CR31], [@CR32]\]. However, loss of Cbl protein in adult mice did not result in an overt skeletal phenotype \[[@CR6]\]. On the other hand, absence of Cbl-b, another member of the Cbl family, resulted in decreased bone volume \[[@CR7]\]. These findings suggest that although Cbl and Cbl-b proteins share significant homologies and identical domain organization \[[@CR2]\], they have different effects on cells that regulate bone mass. One major difference between the two proteins is the absence of Y737 in Cbl-b. Cbl protein phosphorylation of Y737 has been shown to recruit PI3K and regulate PI3K activity \[[@CR16]\]. Studies on osteoblast cell lines have established that PI3K plays an important role in osteoblast function \[[@CR15], [@CR33], [@CR34]\]. In an immortalized human osteoblast cell line, FGFR2--Cbl interaction in lipid rafts resulted in attenuation of PI3K signaling and osteoblast survival \[[@CR18]\]. We recently reported that the lack of Cbl--PI3K interaction promotes decreased osteoclast function while increasing their survival \[[@CR19]\]. In this report, we examined if the lack of this molecular interaction also had an effect on osteoblast differentiation and function.

Cbl is a major PI3K binding protein in several cell types. With a Y \> F mutation on the Cbl--PI3K binding site, the expectation is that loss of this interaction would perturb PI3K-mediated signaling and cell survival. In thymocytes loss of Cbl--PI3K results in decreased AKT phosphorylation \[[@CR35]\], whereas in osteoclasts abrogation of this interaction results in increased AKT phosphorylation, leading to enhance survival \[[@CR19]\]. Others have shown that in human osteoblast cells that express mutated forms of FGFR2 FGFR2--Cbl interaction in lipid rafts triggers attenuation of PI3K/AKT signaling and osteoblast survival \[[@CR18]\]. On the other hand, stimulation of growth factor receptors in YF osteoblasts did not modulate proliferation or PI3K-mediated signaling (Supplementary Fig. 2a, b). Thus, it appears that Cbl--PI3K interaction plays distinct roles in different cell types. In YF osteoblasts, the lack of impact on PI3K-mediated signaling suggests that Cbl-b and/or other proteins (e.g., Src) that are capable of interacting with PI3K might be able to compensate for the lack of Cbl--PI3K interaction and preserve the signaling. It is also likely that another SH2 domain-containing protein might interact with phosphorylated Y737 Cbl and that the observed effects in the YF mice are a consequence of loss of that interaction.

Histological and micro-CT analysis of bones from YF mice indicated that there was an increase in trabecular bone volume (Fig. [2](#Fig2){ref-type="fig"}; Table [1](#Tab1){ref-type="table"}), osteoblast numbers (Fig. [3](#Fig3){ref-type="fig"}b), BFR, mineralizing surface, and MAR compared to WT mice (Fig. [3](#Fig3){ref-type="fig"}e--g). Also, culturing YF bone marrow stromal cells resulted in increased numbers of CFUs and increased proliferation (Fig. [5](#Fig5){ref-type="fig"}a, b). The increase in Col1A expression during differentiation of YF bone marrow cells (Fig. [4](#Fig4){ref-type="fig"}d) suggests that the increase in MAR is driven at least in part by increased matrix protein production. However, other markers of differentiation were unaffected in YF bone marrow cells (Fig. [4](#Fig4){ref-type="fig"}). These combined data suggest that the increased numbers of YF osteoblasts in bone marrow may be in part also due to a secondary effect.

The increased bone volume and increased numbers of nonresorbing osteoclasts and osteoblasts are indicative of an osteopetrotic phenotype in YF mice (Fig. [2](#Fig2){ref-type="fig"} and \[[@CR19], [@CR36]\]). In several osteopetrotic mouse models where bone resorption is compromised due to the absence of osteoclast (c-Fos^−/−^) \[[@CR37]\] or due to impaired osteoclast function (e.g., Src^−/−^ \[[@CR38]\] and Pyk2^−/−^ \[[@CR39]\]), bone formation is also impaired due to a cell autonomous defect in osteoblast activity \[[@CR37], [@CR40], [@CR41]\]. In v-ATPase knockout mice, in which osteoclasts are incapable of degrading the bone matrix, both bone formation and osteoblast numbers increase due to uncoupling \[[@CR42]\]. Osteoclast activity has been regarded as restricted to bone resorption; however, recent studies have suggested that osteoclasts might release anabolic signals that are not linked to their resorption activity \[[@CR29], [@CR30]\]. Our results indicate that cell proliferation was not significantly affected when cells were grown in conditioned medium generated from YF osteoclasts (Fig. [5](#Fig5){ref-type="fig"}c). This could be due to several possibilities. First, in an ex vivo culture system, a secreted factor(s) may not be in sufficient quantity or concentration to influence cell proliferation. Second, cell--cell contact between osteoclasts and osteoblasts may be required for the desired effect on proliferation since direct contact of osteoblasts with the bone marrow precursors is a prerequisite for the generation of mature osteoclasts and to facilitate interaction of the membrane-bound RANKL on osteoblasts with RANK on osteoclasts \[[@CR43]\]. Furthermore, recent studies have indicated that the interaction between the transmembrane ephrinB2 ligand that is present on osteoclasts mediates anabolic signals via the ephB4 receptor present on osteoblasts \[[@CR44]\]. Given that YF osteoclasts are not functional in in vivo and in vitro cultures \[[@CR19]\], we could not test the possibility that a bone matrix-derived factor(s) could influence increased proliferation of osteoblasts in vivo. Given this scenario, it is not likely that YF osteoclasts modulate enhanced proliferation of YF osteoblasts, although more studies are needed to explore this further.

Bone marrow contains several different types of hematopoietic and stromal cells that secrete a variety of growth factors and cytokines that can influence the properties of cells residing in the marrow space \[[@CR45], [@CR46]\]. Our result show that there was a significant increase in the rate of proliferation of MC3T3-E1 cells cultured in YF conditioned medium compared to WT conditioned medium (Fig. [5](#Fig5){ref-type="fig"}d). Comparative analysis of WT and YF condition media showed that the level of the chemokine SDF-1 was elevated in the YF conditioned medium (Table [3](#Tab3){ref-type="table"}). SDF-1, also known as CXCL2, is produced in bone marrow stromal cells and directs the migration of hematopoietic cells to the bone marrow during development \[[@CR47]\]. The SDF-1/CXCR4 signaling axis is essential for several normal physiological functions, including bone remodeling \[[@CR48]\]. For example, SDF-1 has been implicated as a regulator of bone resorption \[[@CR49]\]. SDF-1 also regulates BMP2-mediated osteogenic differentiation in mesenchymal cell lines \[[@CR50]\]. More recently, it has been demonstrated that conditional inactivation of CXCR4 in osteoblast precursors reduces postnatal bone formation due to impaired osteoblast development \[[@CR51]\]. Our results show that expression of both SDF-1 and CXCR4 was substantially increased in YF bone marrow stromal cells (Fig. [6](#Fig6){ref-type="fig"}). In contrast, SDF-1 was not increased in mature osteoblast and bone lining cells (Fig. [6](#Fig6){ref-type="fig"}c, d). Interestingly, the increased expression was restricted to the YF bone marrow milieu since expression levels of SDF-1 and CXCR4 were comparable in WT and YF calvarial cells (Fig. [5](#Fig5){ref-type="fig"}e, f). It is likely that increased SDF-1 in the YF bone marrow environment promotes osteoblast proliferation since both Cbl \[[@CR52]\] and PI3K \[[@CR53]\] are known to participate in SDF-1-mediated signaling. Further studies are needed to specifically analyze the role of Cbl--PI3K interaction in the effects of SDF-1-mediated signaling events that induce proliferation, attachment, and migration of bone marrow stromal cells.

In conclusion, our studies establish that abrogation of Cbl--PI3K interaction results in increased bone volume. While our past studies show that this is primarily due to defective osteoclast function, these new data also suggest that the increased numbers of osteoblasts in vivo and increased proliferation of osteoblasts are due to a secondary effect probably mediated by factors in the marrow cavity, such as SDF-1.
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Supplementary Figure 1. Osteoblast survival is not affected due to lack of Cbl-PI3K interaction. A. WT and YF osteoblasts were grown in complete culture medium for 24 h. Cells were then kept in serum-free media for 72 hrs to induce apoptosis. Cell viability was measured by MTT assay as previously described \[[@CR19]\]. The graph represents % cell survival**.** B and C. Cells were treated with LY294002 (50 □M) for 72 hrs to induce cell death. TUNEL assay was performed to identify apoptotic cells. B. Blue is nuclear staining for DAPI and TUNEL positive cells are green. C. Cells that co stained with DAPI and TUNEL were quantified. The graph represents the % of TUNEL positive cells. Comparable numbers of apoptotic cells were seen for untreated and drug-treated WT and YF osteoblasts. The experiments were performed at least three times and a representative experiment is shown. (TIFF 550 kb)

###### 

Supplementary Figure 2. CblY737F mutation does not affect growth factor induced proliferation or phosphorylation of AKT. A. WT and YF primary osteoblasts were grown for 18 hrs in complete media and then serum starved for 24 hrs. Cells were then treated with 100 ng/mL of indicated growth factor for 5 minutes. Black and white bars indicate WT and YF samples. B. Western blotting was used to determine the levels of Cbl protein, phosphorylated p85 subunit levels, and phosphorylated AKT levels in response to growth factor stimulation for both WT and YF osteoblasts. Levels of phosphorylated proteins were similar between the WT and YF osteoblasts in response to treatment with different growth factors. To quantify changes in the band density, densitometry of the phosphorylated and total protein bands was performed using the ImageJ (NIH, USA). Numbers at the bottom of the bands in each lane indicate the ratio between the phosphorylated and total protein. The experiments were performed at least three times and a representative experiment is shown. (JPG 297 kb)
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